L&T Finance Strong FY26 Performance and Strategic Expansion

L&T Finance Limited announced a robust financial performance for the quarter and financial year ended March 31, 2026. The company reported a consolidated annual profit of ₹2,982.87 crore, a significant growth compared to the previous year. Alongside these financial results, the company announced a final dividend of ₹2.75 per equity share, key executive appointments, and strategic initiatives to enter the pre-paid instruments business and expand its non-convertible debenture borrowing capacity.

FY26 Financial Highlights

For the financial year ended March 31, 2026, L&T Finance reported a consolidated annual profit of ₹2,982.87 crore, up from ₹2,643.42 crore in the previous year. For the fourth quarter (Q4) ending March 31, 2026, the company achieved a quarterly profit of ₹809.16 crore. The total consolidated income for the year reached ₹17,917.03 crore, reflecting the company’s strong operational growth and asset management efficiency.

Dividend and Shareholder Returns

The Board of Directors has recommended a final dividend of ₹2.75 per equity share for the financial year 2025-26, maintaining the same dividend level as the previous year. This dividend is subject to approval by shareholders at the forthcoming Annual General Meeting (AGM) and will be credited within 30 days of the AGM.

Strategic Growth and Business Expansion

L&T Finance is set to expand its business portfolio by entering the pre-paid instruments market, including digital wallets and cards, and acting as a Third-Party Application Provider, pending necessary regulatory approvals. Additionally, the company has secured board approval to raise funds via non-convertible debentures (NCDs) up to an aggregate amount of ₹1,23,500 crore, and to issue cumulative compulsorily redeemable non-convertible preference shares worth ₹6,012 crore during FY2026-27.

Executive Leadership Appointments

To support its future growth, the company has announced key leadership changes. Mr. Sachinn Joshi has been appointed as a Whole-time Director for a period of two years. Furthermore, Mr. Raju Dodti has been appointed as a Whole-time Director for a term of three years. Both appointments are effective upon receiving necessary regulatory and shareholder approvals.

Source: BSE

Previous Article

Jubilant Pharmova Board Meeting Scheduled for May 22, 2026

Next Article

Embassy Developments Limited Company Announces New Employee Stock Option Scheme Grant